Item Posts Archive - Page 7 of 1770 - Medivizor
Navigation Menu

Evaluating the outcomes of invasive versus conservative strategies in older patients with non-ST elevation myocardial infarction.

Evaluating the outcomes of invasive versus conservative strategies in older patients with non-ST elevation myocardial infarction.

Posted by on Aug 27, 2023 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the outcomes of invasive versus conservative strategies in patients older than 70 years with non-ST elevation myocardial infarction (NSTEMI). The data showed that an initial invasive strategy was associated with a significantly lower risk of major cardiac and cerebrovascular events and unplanned revascularization...

Read More

Analyzing the effectiveness and safety of abatacept for rheumatoid arthritis

Analyzing the effectiveness and safety of abatacept for rheumatoid arthritis

Posted by on Aug 27, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell The study investigated the effectiveness and safety of abatacept (Orencia) for patients with rheumatoid arthritis (RA). The analysis concluded that abatacept gave better results to patients with RA compared to other biologic drugs.  Some background RA is a common autoimmune disorder that affects the joints. This condition...

Read More

Evaluating the effectiveness and safety of brentuximab vedotin plus nivolumab consolidation therapy after autologous hematopoietic stem-cell transplantation in patients with high-risk classic Hodgkin lymphoma.

Evaluating the effectiveness and safety of brentuximab vedotin plus nivolumab consolidation therapy after autologous hematopoietic stem-cell transplantation in patients with high-risk classic Hodgkin lymphoma.

Posted by on Aug 27, 2023 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of brentuximab vedotin (BV; Adcetris) plus nivolumab (Opdivo) consolidation therapy after autologous hematopoietic stem-cell transplantation (HSCT) in patients with high-risk relapsed or refractory (r/r) classical Hodgkin lymphoma (cHL). The data showed that the BV plus nivolumab combination...

Read More

Evaluating the effectiveness and safety of platelet rich plasma for the treatment of erectile dysfunction.

Evaluating the effectiveness and safety of platelet rich plasma for the treatment of erectile dysfunction.

Posted by on Aug 27, 2023 in Erectile dysfunction | 0 comments

In a nutshell This study evaluated the effectiveness and safety of platelet-rich plasma (PRP) injections for the treatment of patients with mild and moderate erectile dysfunction (ED). The data showed that PRP was a safe and promising treatment for improving mild to moderate ED. Some background Erectile dysfunction (ED) consists of the inability to...

Read More

Evaluating the effectiveness and safety of Quisqualis indica extract for the treatment of patients with lower urinary tract symptoms.

Evaluating the effectiveness and safety of Quisqualis indica extract for the treatment of patients with lower urinary tract symptoms.

Posted by on Aug 27, 2023 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of Quisqualis indica (Rangoon creeper or Chinese honeysuckle; a type of plant) extract for the treatment of patients with lower urinary tract symptoms (LUTS). The data showed that Quisqualis indica extract was safe and effective for the treatment of these patients. Some background Benign...

Read More